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Abstract
To evaluate microbeam radiation therapy (MRT), for brain tumor treatment, the bystander effect in nonirradiated companion
animals was investigated. Adult rats were irradiated with 35 or 350 Gy at the European Synchrotron Research Facility using
homogenous irradiation (HR) or MRT to the right brain hemisphere. The irradiated rats were housed with nonirradiated rats.
After 48 hours, all rats were euthanized and the frontal lobe proteome was analyzed using 2-dimensional electrophoresis and
mass spectrometry. Proteome changes were determined by analysis of variance (P < .05). Homogenous irradiation increased
serum albumin, heat shock protein 71 (HSP-71), triosephosphate isomerase (TPI), fructose bisphosphate aldolase (FBA), and
prohibitin and decreased dihydrolipoyl dehydrogenase (DLD) and pyruvate kinase. Microbeam radiation therapy increased HSP-
71, FBA, and prohibitin, and decreased aconitase, dihydropyrimidinase, TPI, tubulin DLD, and pyruvate kinase. Cage mates with
HR irradiated rats showed increased HSP-71 and FBA and decreased pyruvate kinase, DLD, and aconitase. Cage mates with MRT
irradiated rats showed increased HSP-71, prohibitin, and FBA and decreased aconitase and DLD. Homogenous irradiation
proteome changes indicated tumorigenesis, while MRT proteome changes indicated an oxidative stress response. The bystander
effect of proteome changes appeared antitumorigenic and inducing radioresistance. This investigation also supports the need for
research into prohibitin interaction with HSP-70/71 chaperones and cancer therapy.
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Introduction
Microbeam radiation therapy (MRT) is an experimental radio-
therapy concept characterized by the delivery of multiple, par-
allel and very narrow (*25-75 mm) microplanar X-ray beams.1
The technique was initially investigated in the 1950s and there
is now international effort to develop its clinical implementa-
tion.2 Specifically, these doses are delivered in parallel beams,
which focus the high dose along narrow microplanar tracks,
thus sparing large volumes of interjacent normal tissue from
radiation exposure.3,4 Microbeam radiation therapy therefore
allows the application of peak X-ray doses, which are greater
than the doses usually used for cancer therapy, by 1 or 2 orders
of magnitude (eg, 150-4000 Gy).1 In theory, this offers a non-
invasive means for treating brain tumors by delivering targeted
radiation doses to precise locations within the brain (ie, the
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exact site of the tumor) without significant functional damage
to the brain tissue outside of the site of irradiation.5
Apart from the potential medical applications, MRT is also
of particular interest to those studying the radiation-induced
bystander effect (RIBE).6,7 Radiation-induced bystander effect
describes the response of nonirradiated cells which receive
signals from irradiated cells.8 Bystander effects have been
documented in vitro9 and in vivo, in animals as diverse as
mice,10 bullfrog tadpoles11 and fish.12 Thus, the bystander
effect can extend the influence of radiation exposure beyond
the cells or animal which received the radiation dose.
Microbeam radiation therapy has been shown to induce a
bystander effect in the nonirradiated hemisphere of an MRT
irradiated rat brain13,14 and also in the brains of completely
nonirradiated “cage mate” rats, which had been housed with
the MRT irradiated rats.15
The bystander effect has been induced following exposure
to nontargeted whole-body radiation dose of less than
10 mGy.5,16 Clearly, this is much less than the radiation doses
used for MRT (see above). However, MRT by its nature does
not involve radiation doses in the mGy range. Nevertheless, in
terms of investigating the MRT-induced bystander effect,
examining the effect caused by a lower MRT dose than would
be employed for actual therapy is important. Thus, the present
investigation used 35 and 350 Gy radiation doses. Three hun-
dred fifty Gy falls within the range which is likely to be used
for MRT (see above), whereas 35 Gy allows for a comparison
of the bystander effect induced with an MRT dose by 1 order of
magnitude less.
In addition, exposure to 35 and 350 Gy HR (ie, by an unseg-
mented beam) has been shown to result in proteomic changes in
the rat brain which are indicative of potential tumorigenesis.14
In contrast, the proteomic response, induced by the bystander
effect in the nonirradiated hemisphere of rat brains exposed to
35 and 350 Gy MRT, indicated a potentially antitumorigenic
response based on reactive oxygen species (ROS)-mediated
apoptosis.14
There are no data on the proteomic changes resulting from
an intermammalian bystander effect induced by MRT.
However, in fish gills, the interanimal RIBE, induced by
whole-body radiation, has also been found to result in a pro-
tective proteomic response.17,18 Since the interanimal bystan-
der effect could be important in our understanding of the
clinical use of MRT, the objective of the present investigation
was to extend the studies summarized above. Therefore, iden-
tical radiation doses were used,in the present investigation, to
investigate this intermammalian bystander effect to those
which were used to investigate the bystander effect in the
nonirradiated hemisphere of an MRT irradiated rat brain.
By analyzing the proteomic changes in the brain of HR and
MRT irradiated rats and the nonirradiated cage mate rats,
which were then housed with these irradiated rats for 48
hours, our aim was to extend our knowledge of the bystander
effect in general and, specifically, the consequences of an
intermammalian bystander effect when using MRT as a radio-
therapeutic approach in the treatment of brain cancer.
Materials and Methods
Rat Husbandry and Homogenous (HR) and Microbeam
(MRT) Irradiation
Rat (adult male, Wistar; 260-280 g), husbandry, radiation pro-
cedures, anesthesia and experimental ethical guidelines, and
licensing have all been previously described.14,15 Briefly, the
rats were supplied by Charles River Laboratories (L’Abrelse,
France) and held in the animal facility at the European Syn-
chrotron Research Facility (ESRF), Grenoble, France, under
European Union directive 2010/63/EU. All experimental pro-
cedures were carried out on anesthetized rats (as described
elsewhere14,15) under guidelines issued by the French govern-
ment and specifically covered by licenses 380325 and
B3818510002 and approved by the International Evaluation
Committee for Animal Welfare and Rights. A total of 45 rats
were used in this investigation; 5 completely untreated rats
taken directly from the ESRF animal facility, 4 rats exposed
to a sham irradiation þ 4 cage mates, 4 rats exposed to 35 Gy
HR þ 4 cage mates, 4 rats exposed to 350 Gy HR þ 4 cage
mates, 4 rats exposed to 35 Gy MRTþ 4 cage mates, and 4 rats
exposed to 350 Gy MRT þ 4 cage mates.
The procedures for positioning the anesthetized rats on the
goniometer and for homogenous field irradiation (HR), using a
broad beam, and microbeam radiation (MRT), using a 100 
14 mm high monochromatic anteroposterior beam, in the ESRF
insertion device (ID) hutch 17 beamline, have also been previ-
ously described.14,15 Microbeam radiation therapy irradiation
was of the right hemisphere using an array composed of 50
quasi-parallel rectangular planar microbeams 25-mm thick with
a 200 mm center-to-center distance. Homogenous irradiation
entrance and MRT peak entrance radiation doses of 35 or
350 Gy were delivered and confirmed using Gafchromic
films.14,15
In addition to completely untreated control rats, which never
left the ESRF animal facility, a sham irradiation control was
included in the study, the purpose being to determine whether
proteomic responses occurred as a result of anesthesia and the
handling and confinement associated with the HR and MRT
irradiation. These sham irradiated rats were anesthetized and
positioned in the ID hutch 17 in the same way and for the same
period of time as the irradiated rats, but no radiation dose was
administered.
Cage Mate Pairing, Tissue Collection, and
Proteomic Analysis
Following irradiation (or sham irradiation), the rats were trans-
ported back to the ESRF animal facility and placed in individ-
ual cages with a single marked, nonirradiated rat. After 48
hours, the rats were deeply anesthetized, beheaded, and dis-
sected.15 Brain tissue samples (5 mm  5 mm  3 mm) were
taken from the center of the irradiation array in the right hemi-
sphere of the irradiated rats and the matching area from sham
irradiated rats, cage mate rats, and completely untreated control
2 Dose-Response: An International Journal
rats. These samples were placed in aluminum foil and imme-
diately frozen in liquid nitrogen and then stored at 80C.
The brain samples from these rats were then analyzed using
2 dimensional (2-D) gel electrophoresis (2-DE). Thirty micro-
gram samples of brain tissue were homogenized in 300-mL
ice-cold 2-D lysis buffer; the buffer composition is detailed
elsewhere.19 The homogenate was clarified, by centrifugation
(18 000g for 5 minutes at 4C) and desalted, using commer-
cially available Pierce desalt columns (Fisher Scientific, Mark-
ham, Ontario, Canada). Total protein concentration was then
determined using a commercially available protein assay kit
(Bio-Rad Laboratories Inc, Mississauga, Ontario, Canada) and
100 mg of total protein was subjected to 2-DE. All 2-DE was
carried out using the Protean 2-DE system, first-dimension
immobilized pH gradient (IPG) strips (pH 3-10), second-
dimension gels (Bio-Rad Laboratories, Inc) and rehydration,
and IPG equilibration and second-dimension running buffers
(all purchased from Bio-Rad Laboratories, Inc). The full 2-DE
protocol, including IPG rehydration, first dimension isoelectric
focusing, second dimension Laemmli/12% acrylamide electro-
phoresis, gel fixing and staining with SYPRO-ruby stain (Bio-
Rad Laboratories, Inc), and gel image capture, using a Fluor-S
Max gel imager (Bio-Rad Laboratories, Inc), has been
described elsewhere.14
Each tissue sample was run individually on a single gel. Any
gels which were not of an acceptable quality for image analysis
were completely rerun using a new 30-mg tissue sample from
the rat brain. The gel images were then analyzed using Phoretix
2-D (V 2004) analytical software (Phoretix International, New-
castle, United Kingdom). It is important to stress this analysis
was carried out as a blind study. The gels were given a random
code number so that, during analysis, it was not known whether
the gel was from an irradiated, sham irradiated, cage mate, or
control rat. The gels were also calibrated for molecular size
(Mr) and isoelectric point (pI) using protein markers (Bio-Rad
Laboratories, Inc) and the gel calibration facility of the Phor-
etix 2-D software.
Two-Dimensional Gel Statistical Analysis
Once gel image analysis had been completed, the gel images
were organized by treatment. Protein spots were then quanti-
fied by normalized volume, a parameter which combines spot
size and intensity to give an index of expression. To fully
illustrate any changes in protein expression, individual normal-
ized spot volumes were divided by the mean normalized spot
volume of the corresponding protein from untreated control
rats to give a “fold-change” index of expression.20 These fold
changes were then compared using analysis of variance fol-
lowed by least square difference analysis; a P < .05 was con-
sidered statistically significant. Consistent protein expression
and the results of this statistical analysis were used to select
protein spots for excision and identification. In other words, the
protein spots selected for protein identification were those
which were present on all the gels in the experiment and which
showed a statistical difference in normalized volume when
compared to the completely untreated control rats. By these
criteria, 11 protein spots were selected (Figure 1). Note that
no protein spots were found which were consistently absent (ie,
downregulated to the point of nondetection) in any experimen-
tal treatment.
In-Gel Tryptic Digestion and Matrix-Assisted Laser
Desorption Ionization QStar XL Mass Spectrometry
Analysis
The full details of In-gel tryptic digestion and matrix-assisted
laser desorption ionization (MALDI) mass spectrometry (MS)
analysis have been described.14 In summary, selected protein
spots were excised, destained, reduced, treated with iodoaceta-
mide, dehydrated, dried, and digested. The digested proteins
were desalted and concentrated in formic acid and analyzed
using a high-resolution QSTAR XL MALDI quadrupole time
of flight (TOF) mass spectrometer (AB Sciex) coupled to a
MALDI 2 ion source with a solid state Nd:YAG laser. Data
acquisition was done by Analyst 1.1 Software (Applied Bio-
systems/MDS Sciex, Foster City, California, USA). Mass spec-
tra in TOF MS and mass spectrometry/mass spectrometry (MS/
MS) mode were in a mass range of 50 to 2500 m/z with a
resolution of 8000 FWHM and a 60 V focusing potential was
used throughout. The MS/MS data analysis was performed
using MASCOT and peptide sequences were compared with
the MS protein sequence database (MSDB). Tolerances for
peptide information were 0.6 Da for MS and MS/MS, and all
Figure 1. Representative 2-dimensional gel of a rat brain indicating
the protein which were found to respond to direct homogenous
radiation (HR) and microbeam radiation therapy (MRT) or in the
brains of cage mate rats housed with those rats which received direct
irradiation and also glial fibrillary acidic protein (GFAP); spot excised
to confirm identification (refer to Discussion). (1) Aconitase, (2) dihy-
drolipoyl dehydrogenase (DLD), (3) dihydropyrimidinase, (4) fructose
bisphosphate aldolase (FBA), (5) glial fibrillary acidic protein (GFAP),
(6) heat shock protein 71 (HSP-71), (7) prohibitin, (8) pyruvate kinase,
(9) serum albumin (S-Alb), (10) triosephosphate isomerase (TPI), and
(11) tubulin.
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information was manually inspected based on y and/or b series
ions (N-terminal carboxyl and bond-cleavage fragments from
the C-terminal sides of the peptide, respectively).
Results
Two-Dimensional Electrophoresis and Protein
Identification
Figure 1 illustrates a representative 2-D gel from the right
hemisphere of a completely untreated control rat and indicates
the protein spots selected for identification. Table 1 lists the
protein identities as well as the theoretical (as listed by the
protein database) and experimentally derived (determined by
2-D gel calibration) molecular sizes (Mr; kDa) and isoelectric
point (pI; pH units). A total of 11 protein spots showed con-
sistent resolution on the gels across the entire experiment and
statistically significant changes in expression (as defined by
normalized spot volume).
The protein spots which were identified in this investigation
as aconitase hydratase, dihydrolipoyl dehydrogenase (DLD),
glial fibrillary acidic protein (GFAP), heat shock cognate
71 kDa (HSP-71), prohibitin, serum albumin (S-Alb), triose-
phosphate isomerase (TPI), and tubulin alpha-1A were the
same identities as those derived from the corresponding protein
spots in our previous investigation.14 The spots identified as
DLD, fructose bisphosphate aldolase (FBA), and pyruvate
kinase were unique to this investigation. In our previous
study,14 we were not alerted to any change in the expression
of these proteins.
The protein spots identified as DLD and prohibitin showed
almost identical theoretical and experimentally derived Mr and
pI (Table 1). This suggests these were intact and unmodified
molecules. The protein spots identified as aconitase hydratase,
dihydropyrimidinase-related protein, FBA, pyruvate kinase,
TPI, and tubulin alpha-1A also showed very similar theoretical
and experimentally derived Mr and pI (Table 1). Again this
suggests these were intact molecules. However, the slightly
different pI values suggest some modification. The experimen-
tally derived Mr of the protein spots identified as S-Alb and
HSP-71 were less than the theoretical Mr (Table 1), which
suggests it is more likely these were breakdown products rather
than intact molecules. It may therefore be more accurate to say
that any changes in these proteins were more likely to be
changes in protein turnover than changes in protein expression.
The experimentally derived Mr of GFAP was greater than the
theoretical Mr (Table 1). However, GFAP has been resolved at
a similar Mr, 45 to 55 kDa,21 and an even greater Mr, 68 kDa.22
Again this suggests GFAP was most likely an intact molecule.
Table 2 quantifies the changes to specific proteins in the right
brain hemisphere of irradiated rats, as a result of HR or MRT,
and in the right brain hemisphere of nonirradiated cage mate
rats housed with the irradiated animals.
Proteomic Responses to Broad Beam Homogenous (HR)
and Microbeam (MRT) Irradiation
After 48 hours of HR, S-Alb, HSP-71, FBA, prohibitin, and TPI
were found to increase in the right hemisphere of the rat brain.
Serum albumin, HSP-71, and FBA were increased by 35 and
350 Gy, whereas prohibitin and TPI were unaffected by 35 Gy
HR but were increased by 350 Gy. Two proteins were found to
be reduced by HR after the same postirradiation interval: pyr-
uvate kinase and DLD. Pyruvate kinase was decreased by 35
and 350 Gy HR, whereas DLD was unaffected by 35 Gy HR
but decreased by 350 Gy HR.
Serum albumin was unaffected 48 hours after 35 or 350 Gy
MRT but, as was the case with HR, HSP-71, FBA, and prohi-
bitin were increased 48 hours after 35 and 350 Gy MRT.
Microbeam radiation therapy also had a similar effect to HR
on pyruvate kinase and DLD; 48 hours after irradiation with 35
or 350 Gy, pyruvate kinase was reduced, and 48 hours after
irradiation with 350 Gy, MRT DLD was reduced. Tubulin,
Table 1. Results of Identification Analysis of the Proteins Indicated in Figure 1.
Gel Spota Protein Description
MSDB Database
Accession Code
Theor Mrb
(kDa)
Theor pIb
(pH units)
Exp Mrc
(kDa)
Exp pIc
(pH units)
MS/MS
MOWSE Scored
1 Aconitase hydratase ACON_MOUSE 85.5 7.09 77.9 8.61 77 (28)
2 Dihydrolipoyl dehydrogenase DLDH_MOUSE 54.3 7.08 52.4 7.96 56 (38)
3 Dihydropyrimidinase-related protein DPYL5_RAT 61.5 6.27 59.1 8.22 58 (26)
4 Fructose-bisphosphate aldolase ALDOC_HUMAN 39.5 6.13 41.1 8.23 59 (44)
5 Glial fibrillary acidic protein GFAP_CARAU 42.6 4.85 53.4 8.66 58 (46)
6 Heat shock cognate 71 kDa protein HSP7C_BOVIN 71.2 5.25 38.4 8.88 59 (43)
7 Prohibitin PHB_BOVIN 29.8 5.43 30.0 6.59 106 (39)
8 Pyruvate kinase KPYM_RAT 57.8 6.30 55.2 8.34 52 (43)
9 Serum albumin ALBU_BOVIN 69.3 5.59 28.8 6.31 59 (39)
10 Triosephosphate isomerase TPIS_BOVIN 26.7 6.20 26.7 8.60 70 (40)
11 Tubulin alpha-1A TBA1A_RAT 50.1 4.84 50.1 6.70 52 (22)
aThe protein spots indicated in Figure 1.
bTheor, theoretically determined, that is, as listed on the MSDB database.
cExp, experimentally determined, that is, as derived by 2-DE gel calibration.
dFigures in parenthesis indicate MOWSE score required for significant homology.
4 Dose-Response: An International Journal
which was unaffected by HR, was also reduced by 35 and
350 Gy MRT. However, in direct contrast to 350 Gy HR, there
was a reduction in TPI 48 hours after 35 Gy MRT. Aconitase
and dihydropyrimidinase, which were also unaffected by HR,
were both reduced 48 hours after exposure to 350 Gy MRT.
Homogenous Radiation: Cage Mate Responses
Heat shock protein 71 and FBA were increased and pyruvate
kinase was decreased in the brain of cage mate rats paired with
rats exposed to either 35 Gy or 350 Gy HR. In other words, the
cage mate rat changes in these proteins were identical to those
seen in the irradiated rats. Dihydrolipoyl dehydrogenase in
cage mate rats showed a decrease when paired with rats
exposed to 35 Gy HR. Therefore, while not identical (DLD
was reduced by both 35 and 350 Gy HR), the HR cage mate
response was also similar to directly irradiated HR rats. TPI,
serum albumin, and prohibitin, which showed increases in HR
rats, were not affected in cage mate rats. Despite being unaf-
fected by HR, aconitase was decreased in cage mates housed
with rats exposed to 35 Gy HR.
Microbeam Radiation Therapy: Cage Mate Responses
Heat shock protein 71 was increased in cage mate rats paired
with rats exposed to 35 and 350 Gy MRT. Thus, HSP-71 was
increased in all irradiated and all cage mate rats. Prohibitin was
also increased in cage mate rats paired with rats exposed to 35
and 350 Gy MRT (ie, the same response as seen with MRT
exposure). This cage mate response was unique to MRT; cage
mates to HR rats showed no change in prohibitin. Fructose
bisphosphate aldolase was increased in cage mates to 35 and
350 Gy MRT rats. This was the same response as seen in cage
mates to 35 Gy and 350 Gy HR-exposed rats. However, only
35 Gy MRT resulted in increased FBA, so the increase seen in
cage mates to 350 Gy MRT-exposed rats occurred despite there
being no change in FBA in the irradiated animals.
Aconitase and DLD were downregulated in the brain of cage
mate rats, after pairing with rats exposed to 350 Gy MRT. This
was similar to the downregulation of aconitase in cage mates
paired with rats exposed to 35 and 350 Gy HR and identical to
the downregulation of DLD in cage mates paired with rats
exposed to 350 Gy HR.
Discussion
Methodology
It should be recognized that tumor control involves the use of 2
MRT microbeam arrays which intersect orthogonally at the site
of the tumor.5,23-25 However, the investigation described here
was intended as an extension of our previous study,13 which
involved MRT-induced bystander effects within the irradiated
animal. Here, it was essential to ensure 1 hemisphere only was
irradiated so that any proteomic changes in the completely
nonirradiated hemisphere were due to a bystander effect.
Therefore, a single MRT beam was used.14 Since the objective
of the present study was to compare bystander effect proteomic
changes which occur within the irradiated rat with bystander
effect proteomic changes induced in completely nonirradiated
rats, we deliberately chose to use an identical radiation proto-
col, as well as an identical protein extraction method and 2-DE
format. However, as stated before,14 we concede that alterna-
tive protein extraction methods or narrower pH ranges may
Table 2. Fold Change (HR or MRT or Cage Mates to HR or MRT Normalized Spot Volume/Mean Handling Control Normalized Spot Volume)
in the Expression of 11 Proteins Indicated in Figure 1.a
Direct Irradiation;
Homogenous Radiation
Direct Irradiation;
Microbeam Radiation
Therapy
Cage Mates;
Homogenous Radiation
Cage Mates; Microbeam
Radiation Therapy
Protein 35 Gy 350 Gy 35 Gy 350 Gy 35 Gy 350 Gy 35 Gy 350 Gy
Aconitase 0.8 (0.7/1.0) 1.0 (0.8/1.1) 0.6b (0.5/0.7) 0.5b (0.3/0.7) 0.6b (0.5/0.7) 1.0 (0.8/1.3) 0.9 (0.7/1.1) 0.5b (0.3/0.7)
Dihydrolipoyl
dehydrogenase
1.0 (0.8/1.1) 0.2b (0.2/0.3) 0.9 (0.5/1.1) 0.3b (0.2/0.5) 0.5b (0.4/0.6) 1.0 (0.5/1.4) 1.0 (0.5/1.9) 0.3b (0.1/0.8)
Dihydropyrimidinase 0.9 (0.6/1.2) 1.0 (0.6/1.1) 0.9 (0.6/1.1) 0.4b (0.2/0.6) 1.0 (0.7/1.4) 0.9 (0.8/1.2) 0.9 (0.5/1.1) 1.1 (1.1/1.2)
Fructose bisphosphate
aldolase
1.4b (1.3/1.4) 1.3b (1.2/1.6) 2.3b (2.2/2.5) 1.3b (1.2/1.8) 1.8b (1.4/2.1) 1.7b (1.2/2.0) 1.7b (1.3/2.2) 2.5b (2.4/2.6)
Glial fibrillary acidic
protein
1.0 (0.6/1.4) 1.0 (0.8/1.1) 1.1 (0.9/1.3) 1.0 (0.7/1.3) 1.0 (0.7/1.5) 1.2 (0.8/1.4) 1.0 (0.8/1.5) 0.9 (0.8/1.1)
Heat shock protein 71 2.1b (1.4/2.9) 1.3b (1.2/1.7) 2.5b (1.9/3.4) 3.3b (1.7/4.3) 4.4b (3.4/5.2) 4.9b (4.4/5.7) 4.1b (3.4/4.7) 3.7b (1.8/6.4)
Prohibitin 1.2 (0.9/1.5) 2.1b (1.4/3.3) 1.7b (1.5/1.9) 1.6b (1.2/2.2) 1.2 (0.7/1.4) 1.2 (0.7/1.8) 1.3 (0.9/1.6) 1.9b (1.6/2.5)
Pyruvate kinase 0.5b (0.3/0.7) 0.3b (0.3/0.3) 0.4b (0.2/0.6) 0.2b (0.2/0.2) 0.5b (0.3/0.9) 0.3b (0.2/0.5) 0.5b (0.3/0.9) 0.5b (0.2/0.9)
Serum albumin 2.5b (2.0/3.1) 2.5b (1.8/3.1) 1.0 (0.6/1.4) 2.0b (1.6/2.5) 1.3 (0.8/1.8) 1.3 (0.5/2.0) 1.0 (0.5/1.6) 1.0 (0.5/1.7)
Triosephosphate
isomerase
0.8 (0.7/1.1) 1.8b (1.4/2.1) 0.7b (0.7/0.7) 1.0 (0.7/1.1) 1.0 (1.0/1.0) 0.8 (0.7/1.1) 0.9 (0.9/1.1) 1.0 (0.9/1.0)
Tubulin 0.9 (0.9/1.0) 0.8 (0.7/1.1) 0.2b (0.1/0.4) 0.3b (0.3/0.5) 0.9 (0.6/1.2) 1.0 (0.6/1.2) 1.0 (0.7/1.1) 1.1 (0.8/1.3)
Abbreviations: HR, homogenous irradiation; MRT, microbeam radiation therapy.
aData shown as mean and, in parentheses, the min/max fold change (n ¼ 5 handling control rats and n ¼ 4 irradiated or cage mate rats).
bA significant change (P < .05) in protein expression compared with the control rats.
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reveal additional proteomic changes and the proteins reported
here are not assumed to be an exhaustive list.
Sham irradiation was not found to affect any of the protein
spots resolved on the gels of the sham irradiated or the cage
mate rats which were paired with the sham irradiated rats.
There were also no protein spots which were unique to, or
absent from, the gels from sham irradiated rats or their cage
mates. This suggests that anesthesia and the restraints neces-
sary for irradiation did not exert a significant effect on the brain
proteome.
Homogenous Radiation: Proteomic Evidence for
Radiation Induced Cancer Progression
The increase in S-Alb and TPI and the decrease in DLD in
irradiated rats 48 hours after HR exposure were identical to the
responses, which occurred between 4 and 12 hours after irra-
diation with the same 350 Gy HR doses.14 Increased S-Alb
albumin and TPI and decreased DLD have all been associated
with tumor development or cancer progression.14 The present
investigation therefore supports the suggestion that focal high-
dose HR (particularly 350 Gy) may induce tumorigenesis in the
rat brain.14
The increase in prohibitin 48 hours after HR and MRT
irradiation also showed considerable consistency to the
increases in the same proteins at up to 12 hours after irradiation,
with HR or MRT,14 to 48 hours after irradiation. Therefore, the
present investigation provides additional evidence that prohi-
bitin is increased in the mammalian brain following irradiation.
However, the association between prohibitin and cancer is less
well defined.14 As a result, the role of prohibitin in terms of
causing cancer cell proliferation or suppression is regarded as
controversial.27
The increase in FBA 48 hours after HR and MRT was not
seen 4 to 12 hours after X-ray exposure,14 which suggests that a
48-hour interval following irradiation was required to induce
this change. In addition to X-ray exposure, FBA has been
shown to be increased by gamma26 and ultraviolet28 radiation.
However, like prohibitin, increased FBA is not always associ-
ated with cancer. An increase has been seen in colorectal can-
cer29,30 and in a head and neck cancer cell line (FaDuDD), under
hypoxia,31 but a decrease in FBA has been recorded in squa-
mous cell carcinoma32 and in HT-29 cells expressing the can-
cer stem cell marker CD133.33
Microbeam Radiation: Proteomic Evidence for Induced
Oxidative Stress Response
Previously, in the brain of MRT irradiated rats, the increase in
S-Alb and TPI and the decrease in DLD, following HR, were
also accompanied by the HR- and MRT-induced increase in
aconitase, another well-documented indicator of tumorigenesis.14
However, in the present investigation, there was no change in
aconitase 48 hours after HR irradiation. Furthermore 48 hours
after MRT, there was a reduction in aconitase expression.
Collectively, these results suggest that the HR-induced effect
on aconitase is limited to somewhere between 12 and 48 hours
and that 48 hours after irradiation MRT had the opposite effect
on aconitase to that seen between 4 and 12 hours after
irradiation.
There is evidence that reducing aconitase activity is a factor
in the metabolic rearrangement seen in cancer cells and, as a
result, a reduction in expression may be an indicator or poor
prognosis in gastric cancers.34 However, there is little doubt
that radiation in general35,36 and radiotherapy in particular37
result in oxidative stress. Aconitase itself is not only highly
susceptible to oxidation,38 but aconitase activity has also been
shown to decrease, within 3 days after gamma radiation, spe-
cifically because of mitochondrial damage due to the action of
ROS.39 Dihydropyrimidinase and tubulin, proteins which were
not found to show any change in expression between 4 and
12 hours after irradiation,14 but which did show a decline in
the present study, 48 hours after irradiation, are also known to
be susceptible to oxidation damage and loss.40,41 Moreover,
35 Gy MRT also resulted in a decline in TPI, that is, again the
opposite effect to that caused by the same dose HR. Triosepho-
sphate isomerase reduction is known to stimulate antioxidant
metabolism and acts to prevent excessive ROS accumulation.42
A decline in pyruvate kinase, as was consistently the result 48
hours after HR and MRT, irrespective of radiation dose, also
results in the resistance to ROS, by inhibiting TPI via accumu-
lation of phosphoenolpyruvate, that is, pyruvate kinase inhibi-
tion, via the resulting substrate accumulation, initiates a
feedback mechanism which acts on TPI.43 We therefore pro-
pose these results could be indicative of a radiation-induced
oxidative stress response. Specifically, following MRT expo-
sure, the decline in oxidation sensitive aconitase, dihydropyr-
imidinase, and tubulin combined with the counteracting
antioxidant response of TPI and pyruvate kinase could be indi-
cative of the “oxidative balance” which occurs between oxida-
tive damage and antioxidant mechanisms.44
Bystander Effect-Induced Proteomics: Antitumorigenesis
and Radioresistance
The increase in HSP-71, in the brain of cage mate rats, was the
only proteomic change in the present investigation which was
similar to those induced by a bystander effect in the nonirra-
diated hemisphere of an MRT irradiated rat brain.14 Perhaps
most significantly the brains of cage mate rats did not include
the proteomic changes previously associated with oxidative
stress-mediated potentially antitumorigenic apoptosis; specifi-
cally, TPI, prohibitin, and tubulin did not show a decrease and
GFAP did not show an increase.14 Indeed, the increase in pro-
hibitin, in the nonirradiated cage mate rat brain, was the oppo-
site response to the decrease seen in the nonirradiated
hemisphere of rats following cranial MRT irradiation.14 It is
also significant that the cage mate brain reductions in DLD,
aconitase, and pyruvate kinase and the increase in FBA, while
being identical to the reductions seen in irradiated rat brains,
were not part of the bystander effect proteome changes in the
nonirradiated hemisphere of rats following cranial MRT
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irradiation.14 Therefore, we conclude the present investigation
provides proteomic evidence for a fundamental difference
between the proteomic response in the brains of nonirradiated
cage mate rats housed with irradiated rats and the proteomic
response in the nonirradiated hemisphere of a rat brain irra-
diated by MRT.14
Despite the uncertainty between prohibitin expression and
cancer progression (see above, Homogenous Radiation; Pro-
teomic Evidence for Radiation Induced Cancer Progression),
increased prohibitin expression can be the basis for tumor sup-
pression.45 Among its roles, prohibitin is a regulator of mito-
chondrial assembly.46 One recent review has therefore
highlighted the importance of prohibitin in preventing tumor-
igenesis, by stabilizing mitochondria and improving the effi-
cacy of cancer treatment,47 and 2 others have highlighted
prohibitin mediated processes as targets for chemotherapy.48,49
Specific examples of chemotherapeutic agents and increased
prohibitin include playtycodin50 and etoposide.51
Apart from the reduction in prohibitin, the potential antitu-
morigenic consequences of a cage mate bystander effect is
supported by the decrease in DLD. Dihydrolipoyl dehydrogen-
ase expression increased in lymphoma cells,52 which suggests
that DLD downregulation in the cage mates would if anything
be antitumorigenic. Interestingly, the same study52 also mir-
rored the present investigation by showing a concomitantly
higher expression of prohibitin in resting B cells compared with
lymphoma cells.
In addition, one of the key proteomic responses in the brains
or all nonirradiated rats which had been paired with HR or
MRT irradiated rats was the increase in FBA. Fructose bispho-
sphate aldolase acts to improve cell function53 by being part of
an antioxidant protective response.54,55 However, FBA is a
target for oxidative stress.56 An increase would therefore pre-
sumably compensate for any oxidative loss. Increased FBA is
also a marker of increased radioresistance57 or lower radiosen-
sitivity.28 Given that cage mate rats were not exposed to radia-
tion, yet showed a similar increase in FBA to the HR and MRT
irradiated rats, this common response adds further evidence to
the conclusion that the bystander effect and induced radiore-
sistance may not be due to the same mechanism.58-60
Proteomic evidence from the nonirradiated hemisphere of a
rat brain irradiated by MRT strongly suggested a bystander
effect which resulted in antitumorigenic response based on
oxidative stress-induced apoptosis.14 The proteomic data from
the present investigation suggests a bystander effect in a non-
irradiated rat brain, induced by the proximity of irradiated rats,
is antitumorigenic, primarily via the stabilization of mitochon-
dria, and may also confer a degree of radioresistance. Thus,
despite differences in the actual proteins which show changes
in expression, there may be some common aspects of the pro-
teomic responses of the bystander effect induced in the non-
irradiated hemisphere of an MRT irradiated rat brain and the
bystander effect induced by an irradiated rat, in the brain of a
completely nonirradiated animal.
The release of volatile secretions, as is the case in irradiated
mice,61 is one possible chemical signal vector which could
induce these bystander effect proteomic changes. However
work using fish, separated by a physical barrier, has also pro-
vided evidence for a physical component to the bystander
signal.62
Bystander Effect Proteomics: HSP-71 and the Prevention
of Neurological Degeneration
One other finding from our previous study involving the
bystander effect in the nonirradiated hemisphere of an MRT
irradiated rat was the potential role of HSP-71 in ensuring that
the antitumorigenic responses of GFAP, TPI, tubulin, and pro-
hibitin are not negated by the same proteins being instrumental
in neurodegeneration or the onset of neurological disorders,
such as Alzheimer’s or Huntington’s disease or schizophre-
nia.14 In the present investigation, changes in GFAP or TPI
were not part of the cage mate/intermammalian proteomic
response. However, FBA, an increase of which could be part
of a protective/antitumorigenic response (see above), is both
upregulated63,64 and oxidized65,66 in the brain of patients with
Alzheimer disease. In addition, prohibitin is increased in the
frontal cortex of patients with Parkinson disease.67 Therefore a
similar question exists, albeit involving different proteomic
responses, to that raised by bystander effect proteomic changes
in the nonirradiated hemisphere of an MRT irradiated rat
brain,14 as to whether the advantages of any potentially anti-
tumorigenic proteomic changes could be negated by a detri-
mental effect on neurological function, also applies to the
intermammalian bystander effect.
Heat shock protein 71 is the constitutively expressed mem-
ber of the HSP-70 family.68 Despite its inconsistency or contra-
dictory association with cancer,69 HSP-70/71 is (i) well
documented as a chaperone, (ii) critical to ensuring the correct
cellular response to neuronal stress tolerance, and (iii) protects
against all of the neurological disorders listed above.14 Heat
shock protein 70 is also a positive predictor of survival follow-
ing non-small cell lung cancer chemotherapy.70 We therefore
propose a similar integrative role for HSP-71 in the responses
of the brain of a cage mate rat housed with an irradiated rat as
we have for the nonirradiated hemisphere of an MRT irradiated
rat brain.14 We also propose that determining whether FBA and
prohibitin act in a tumor suppressive and radioresistant capac-
ity, in companion animals to those exposed to radiation, now
warrants specific experimental attention.
Conclusion
This investigation has demonstrated proteomic evidence for a
RIBE in nonirradiated rats housed with rats exposed to HR or
MRT. We propose these responses are potentially protective,
specifically antitumorigenic, and possibly confer radioresis-
tance. The increase in prohibitin was similar to the result of a
bystander effect in the nonirradiated hemisphere of an MRT
irradiated rat brain. This investigation therefore further sup-
ports the existing need for research into the role of prohibitin
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in cancer therapy particularly with the interaction of HSP-70/
71 chaperones.
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